The European Commission is looking at the possibility of introducing an EU-level mechanism for issuing emergency use authorizations to speed up the availability of COVID-19 vaccines amid criticism of the slow pace of the roll-out across the bloc.
Coronavirus Notebook: EU Moots Emergency Use Authorization Scheme For Vaccines, Janssen Product Up For 11 March Approval
Celltrion’s regdanvimab is undergoing an emergency use procedure in Europe, the European Medicines Agency and the health authorities in Canada have jointly published clinical data on the Moderna vaccine, and Canada has approved two versions of the AstraZeneca/Oxford University jab.
